A Phase 3, randomized, modified double-blind, active-controlled, parallel-group, 4-arm study to investigate the mixed vaccination schedules of a 21-valent pneumococcal conjugate vaccine and a 20-valent pneumococcal conjugate vaccine in healthy infants an

Project: Research project

Project Details

StatusActive
Effective start/end date7/19/24 → 7/18/29

Funding

  • Sanofi Pasteur, Inc: $25,547.00